BAILLIE GIFFORD & CO

Holdings History for Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAP)

Symbol: ADAP on Nasdaq
Investment type: Equity - Shares of Stock
Class: Ordinary Shares, par value GBP 0.001 per share
Latest Disclosed Ownership: 70.9M shares
Security Ownership: 4.6%

Shares, Excluding Options vs Price

Value, Excluding Options

BAILLIE GIFFORD & CO ownership in Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

2025-02-12 - BAILLIE GIFFORD & CO has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 70.9M shares of Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP). This represents 4.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BAILLIE GIFFORD & CO	4.6%		$41.8M	70.9M			$0.59	13G/A	12/31/2024	12 Feb 2025 10:25:35

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	0%	$6.37M	11.8M	-4,956,765	-29.5%	$0.54	Q4 2024
9/30/2024	0.01%	+0%	$15.9M	16.8M	+1,626,657	+10.7%	$0.95	Q3 2024
6/30/2024	0.01%	0%	$14.8M	15.1M	-722,672	-4.55%	$0.97	Q2 2024
3/31/2024	0.02%	0%	$25.1M	15.9M	-40,265	-0.25%	$1.58	Q1 2024
12/31/2023	0.01%	0%	$12.6M	15.9M	-1,235,269	-7.2%	$0.79	Q4 2023
9/30/2023	0.01%	0%	$13.4M	17.1M	-28,726	-0.17%	$0.78	Q3 2023
6/30/2023	0.01%	+0%	$15.9M	17.2M	+64,133	+0.37%	$0.93	Q2 2023
3/31/2023	0.02%	0%	$18.7M	17.1M	-57,937	-0.34%	$1.09	Q1 2023
12/31/2022	0.03%	+0%	$25.1M	17.2M	+2,505,003	+17.1%	$1.46	Q4 2022
9/30/2022	0.02%	0%	$15.8M	14.7M	-656,410	-4.28%	$1.07	Q3 2022
6/30/2022	0.03%	0%	$26M	15.3M	-59,192	-0.38%	$1.70	Q2 2022
3/31/2022	0.02%	+0%	$31.7M	15.4M	+1,624,186	+11.8%	$2.06	Q1 2022
12/31/2021	0.03%	+0%	$51.6M	13.8M	+931,372	+7.26%	$3.75	Q4 2021
9/30/2021	0.03%	+0%	$66.3M	12.8M	+1,128,061	+9.64%	$5.17	Q3 2021
6/30/2021	0.02%	+0%	$49.8M	11.7M	+229,402	+2%	$4.26	Q2 2021
3/31/2021	0.03%	+0%	$60.9M	11.5M	+1,109,737	+10.7%	$5.31	Q1 2021
12/31/2020	0.03%	+0.01%	$55.8M	10.4M	+3,279,717	+46.3%	$5.39	Q4 2020
9/30/2020	0.04%	+0.01%	$56.5M	7.08M	+1,788,394	+33.8%	$7.98	Q3 2020
6/30/2020	0.04%	+0.01%	$53M	5.29M	+935,646	+21.5%	$10.01	Q2 2020
3/31/2020	0.01%	+0%	$11.8M	4.35M	+66,478	+1.55%	$2.72	Q1 2020
12/31/2019	0%	+0%	$5.15M	4.29M	+122,738	+2.95%	$1.20	Q4 2019
9/30/2019	0.01%	+0%	$6.29M	4.16M	+20,967	+0.51%	$1.51	Q3 2019
6/30/2019	0.02%	+0%	$16.7M	4.14M	+304,650	+7.94%	$4.02	Q2 2019
3/31/2019	0.02%	+0%	$16.5M	3.84M	+139,669	+3.78%	$4.30	Q1 2019
12/31/2018	0.03%	+0%	$21.3M	3.7M	+281,894	+8.25%	$5.75	Q4 2018
9/30/2018	0.05%	+0.01%	$46.3M	3.42M	+384,366	+12.7%	$13.56	Q3 2018
6/30/2018	0.04%	+0.01%	$36M	3.03M	+467,852	+18.2%	$11.87	Q2 2018
3/31/2018	0.03%	+0.01%	$28.8M	2.57M	+644,816	+33.6%	$11.23	Q1 2018
12/31/2017	0.02%	+0%	$12.8M	1.92M	+541,289	+39.2%	$6.68	Q4 2017
9/30/2017	0.01%	+0%	$11.3M	1.38M	+55,996	+4.23%	$8.19	Q3 2017
6/30/2017	0.01%	+0%	$5.94M	1.32M	+402,324	+43.7%	$4.49	Q2 2017
3/31/2017	0.01%		$5.08M	921K			$5.51	Q1 2017
12/31/2016	0.01%		$3.73M	921K			$4.05	Q4 2016
9/30/2016	0.01%	+0.01%	$6.49M	921K	+491,284	+114%	$7.05	Q3 2016
6/30/2016	0.01%		$3.5M	430K			$8.15	Q2 2016
3/31/2016	0.01%	+0.01%	$3.49M	430K	+429,700	NEW	$8.13	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.